The latest market forecast report on Fish Free Omega-3 Ingredients market published by Transparency Market Research includes the global industry analysis and opportunity assessment for the period 2019-2029. The revenue from the global Fish-Free Omega-3 Ingredients market is estimated at ~ $ 590 million in the 2019which is expected to increase at a CAGR of ~ 9%to reach a value of ~ $ 1.3 billion by 2029.
Vegans and vegetarians are demanding fish-free omega-3 ingredients and supplements
All three types of omega-3s are important, but there is evidence that DHA and EPA have unique benefits, particularly in improving brain health, reducing inflammation, and improving retinal health. It is difficult for vegans (vegetarians who only eat foods derived from plant sources) and vegetarians to get sufficient amounts of omega-3 fatty acids in their diet because the two essential omega-3 fatty acids DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid ) come mainly from fish and animal sources. Omega-3 ingredients from plant sources only contain ALA (alpha-linolenic acid), a precursor form that is converted into DHA and EPA in the body.
Because there are not enough vegan food sources for EPA and DHA, those who follow a vegan diet often have fewer fatty acids in their blood. For this reason, taking into account the vegan and vegetarian diet, the manufacturers develop products made from algae oil or plant-based products such as chia seeds, linseed oil, rapeseed oil, hemp seeds, walnuts and others that grow as fish-free omega. 3 ingredients.
Growing need for an alternative to omega-3 ingredients from fish
Many fish-derived oil additives on the market are rancid, that is, oxidized. Rancid oils / fats can damage cells and contribute to arteriosclerosis. Free radicals from rancid oils are known to damage DNA cells. Free radicals are produced by both toxins and normal bodily processes and can damage the arteries and act as carcinogens as well.
Fat-soluble pollutants such as polychlorinated biphenyls can biomagnify in marine food chains and, in concentrated quantities, end up in fish-like oil additives. This build-up causes contamination and accelerates the oxidation process of supplement oils / fats.
Request a Sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=68579
The demand for algae-based omega-3 dietary supplements is expected to grow rapidly
Fish is the main source of omega-3 for the manufacture of various dietary supplements. Fish get omega-3s from eating seaweed. Therefore, the use of algae as a new alternative source to fish is expected to expand rapidly in the fish-free omega-3 ingredient market.
Dietary supplements made from algae oil have the same omega-3 benefits and nutritional content as fish-derived oils. Algae oil is free from contaminants such as heavy metals, bioaccumulated toxins and pollutants. Vegan diets lack EPA and DHA, which can be consumed through algae oil supplements.
Omega-3 – Preferred ingredient for convenience and processed foods
Growing health awareness and preference among consumers for processed foods / diets with low levels of fat, sugar and salt are factors that are likely to lead food and beverage manufacturers to review current marketing practices and apply new techniques to increase their share of sales in fish -free market for omega-3 ingredients.
- In May 2004, the World Health Organization (WHO) launched a global strategy for diet, physical activity and health and made certain recommendations to the food and beverage industry, including limiting the content of saturated fats and trans fats, sugar and salt in existing products and promoting healthy and healthy nutritious products.
In North America, the millennial population accounts for a large proportion of the consumption of ready-to-eat and processed foods. The consumption of takeaway food has also increased significantly due to its convenience, which is expected to continue to fuel the growth of the fish-free omega-3 ingredients market over the forecast period.
Fish-Free Omega-3 Ingredients Market: Lengthy Regulatory Approval Process
The limiting factor in the fish-free omega-3 ingredient market is the slow government approval of health claims. For drugs and pharmaceuticals, approval for prescribing takes an additional six to twelve months after completion of the phase III study. There are several steps to getting the drug approved for prescription, including the discovery and development process, which begins in the laboratory. In the second step, pharmaceuticals are subjected to laboratory and animal tests in order to clarify fundamental safety issues. The third step involves clinical research, where drugs are tested on people to make sure they are effective and safe. An FDA review will take place later for final approval. Any drug, supplement, or drug typically takes about 10 years to develop and be approved for prescription. To sanction any health claim, the waiting time is quite long, which is a major drag on the growth of the fish-free omega-3 ingredient market.